Site Roadmap: Early-Phase Oncology Trials

As the demand for Phase 1 oncology trials increases, research sites are faced with unique challenges and opportunities in early-phase studies. This breakout will focus on the critical factors that sites must consider when taking on these complex trials. Panelists will highlight valuable resources for sites eager to expand their capabilities in this vital area, including a comprehensive “checklist” for sites preparing to participate in First in Human (FIH) or Phase 1 trials. Learn how to prepare your site for key elements of phase 1 trials including staffing, facilities, infrastructure, and patient access.

Speakers

Nashat Gabrail

Renee Smith

Sofie Vanderplaetsen